See the video below for PSI Chair Robert Cuffe award Craig Mallinckrodt his 2014 RSS/PSI prize for statistical excellence in the pharmaceutical industry. The video is of the whole awards ceremony. The pharmaceutical prize section starts at 6m 38s.
The award recognises statistical innovation or outstanding application of existing statistical practice that has strengthened investigations in the pharmaceutical industry. The judges in particular look for work that can inform other users of statistics in the pharmaceutical industry and widen the applicability of their work. This was particularly in evidence in Craig’s nomination.
Craig is a research fellow at Eli Lilly & Company, based in Indianapolis, USA. His book, Preventing and Treating Missing Data in Longitudinal Clinical Trials, provides a comprehensive ‘analytic roadmap’ for missing data in longitudinal clinical studies. His work drew together many strands of academic research on analysis techniques and has since influenced regulators, academics and pharmaceutical companies alike in their approach to the treatment of missing data. It has also been praised for being accessible to a wide variety of researchers.
For your chance to be recognised in front of your peers, start thinking about what work from your department could win the 2015 award. Nominations will open in the new year, so get planning!
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
